drugset / Trial / NCT01462708

Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects

NCT01462708 ↗

Phase 1 Completed 16 enrolled Institute for Neurodegenerative Disorders
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to assess MK-9470 Positron Emission Tomography (PET) imaging as a tool to evaluate the activity of the CB-1 receptor in the brain.

Timeline

Start
2011-05
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]MK-9470 Unknown 10 unknown Other

Indications